Table 1 Demographic and clinical characteristics of the patients enrolled in the study
Age (mean, SD) | 62.45 ± 11.2 | |
|---|---|---|
Sex | Male | 12 (41.4%) |
Female | 17 (58.6%) | |
Race | Caucasian | 9 (31%) |
African American | 19 (65.5%) | |
Asian | 1 (3.5%) | |
Location | Lung | 8 (26.5%) |
Colon | 4 (14%) | |
Breast | 4 (14%) | |
Endometrial | 2 (7%) | |
Stomach | 2 (7%) | |
MM | 2 (7%) | |
Pancreas | 2 (7%) | |
Esophageal | 1 (3.5%) | |
Prostate | 1 (3.5%) | |
Cervix | 1 (3.5%) | |
Hodgkin | 1 (3.5%) | |
Bladder | 1 (3.5%) | |
Pathology (solid) | Adenocarcinoma | 24 (82.8%) |
Small cell carcinoma | 1 (3.5%) | |
Squamous cell carcinoma | 1 (3.5%) | |
Stage (for solid) | Stage 2 | 1 (3.5%) |
Stage 3 | 10 (34.5%) | |
Stage 4 | 12 (41.8%) | |
Previously treated | Yes | 21 (27.6%) |
No | 8 (82.4%) | |
Treatment type | Chemotherapy alone | 23 (79.3%) |
Chemotherapy plus immunotherapy | 6 (20.7%) | |